Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01562275
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms
Genentech, Inc. 67
Early research (Phase 1)Looking for participantsNCT06536400
What this trial is testing

Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation

Who this might be right for
Solid Tumors
Haisco Pharmaceutical Group Co., Ltd. 316
Testing effectiveness (Phase 2)Study completedNCT01915498
What this trial is testing

Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation

Who this might be right for
Hematologic Neoplasms
Celgene 345
Early research (Phase 1)Study completedNCT06619392
What this trial is testing

A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects

Who this might be right for
Pain
Shandong Suncadia Medicine Co., Ltd. 44
Early research (Phase 1)Study completedNCT02386436
What this trial is testing

A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy Subjects

Who this might be right for
Scleroderma, Systemic
GlaxoSmithKline 41
Early research (Phase 1)Study completedNCT00060632
What this trial is testing

Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 46
Early research (Phase 1)WithdrawnNCT01452334
What this trial is testing

Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy

Who this might be right for
Non-Hodgkin's LymphomaHodgkin LymphomaMultiple Myeloma+1 more
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00542464
What this trial is testing

Multiple-Dose, Dose-Escalation Safety, Pharmacodynamics, and Pharmacokinetics Study of Imprime PGG™ Injection

Who this might be right for
Healthy
HiberCell, Inc. 12
Early research (Phase 1)Study completedNCT03248843
What this trial is testing

PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
3D Medicines (Sichuan) Co., Ltd. 35
Early research (Phase 1)Study completedNCT00515385
What this trial is testing

A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults

Who this might be right for
West Nile Virus
MacroGenics 40
Early research (Phase 1)Study completedNCT01723475
What this trial is testing

First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bayer 47
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Early research (Phase 1)Ended earlyNCT01453387
What this trial is testing

MSC2015103B in Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono 28
Testing effectiveness (Phase 2)Ended earlyNCT04220411
What this trial is testing

AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Arjil Pharmaceuticals LLC 17
Post-approval studies (Phase 4)Study completedNCT02391844
What this trial is testing

Open-Label Study of Oxycodone/APAP to Treat Post-Operative Pain Following Arthroscopic Knee Surgery

Who this might be right for
Disorder of Knee
International Clinical Research Institute 50
Early research (Phase 1)UnknownNCT02453464
What this trial is testing

A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 36
Early research (Phase 1)Study completedNCT01381744
What this trial is testing

Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers

Who this might be right for
Plague
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT07155499
What this trial is testing

A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.

Who this might be right for
Rhinitis, Allergic, Seasonal
AO GENERIUM 150
Testing effectiveness (Phase 2)Study completedNCT02925000
What this trial is testing

Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy

Who this might be right for
Cancer
Taiwan Liposome Company 46
Early research (Phase 1)Study completedNCT01708564
What this trial is testing

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Who this might be right for
Hemophilia
rEVO Biologics 15
Next Page